LifeStance Health Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,495	1,424	1,251	1,056	859.54	667.51
Revenue Growth (YoY)	16.46%	13.86%	18.50%	22.82%	28.77%	151.36%
Gross Profit	1,495	1,424	1,251	1,056	859.54	667.51
Selling, General & Admin	1,396	1,345	1,212	1,164	1,001	899.73
Depreciation & Amortization Expenses	54.32	54.75	70.95	80.44	69.2	54.14
Total Operating Expenses	1,450	1,400	1,283	1,245	1,070	953.86
Operating Income	44.83	24.15	-31.61	-189.13	-210.17	-286.35
Interest Expense	-10.38	-11.66	-26.54	-21.22	-19.93	-38.91
Other Non-Operating Income (Expense)	-0.85	-0.12	0.54	3.77	-2.63	-7.84
Total Non-Operating Income (Expense)	-11.24	-11.79	-26	-17.45	-22.56	-46.75
Pretax Income	33.59	12.36	-57.61	-206.58	-232.73	-333.11
Provision for Income Taxes	10.4	2.7	-0.17	-20.32	-17.17	-25.91
Net Income	23.2	9.66	-57.44	-186.26	-215.56	-307.2
Net Income Attributable to Preferred Dividends	-	-	-	-	-	36.75
Net Income to Common	23.2	9.66	-57.44	-186.26	-215.56	-343.95
Shares Outstanding (Basic)	387	386	379	367	355	328
Shares Outstanding (Diluted)	392	391	379	367	355	328
Shares Change (YoY)	2.34%	3.16%	3.18%	3.43%	8.47%	8.33%
EPS (Basic)	0.06	0.03	-0.15	-0.51	-0.61	-1.05
EPS (Diluted)	0.06	0.02	-0.15	-0.51	-0.61	-1.05
Free Cash Flow	142.63	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	29.63%	28.39%	-	-	-	-
Free Cash Flow Per Share	0.36	0.28	0.23	-0.16	-0.07	-0.26
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	3.00%	1.70%	-2.53%	-17.92%	-24.45%	-42.90%
Profit Margin	1.55%	0.68%	-4.59%	-17.64%	-25.08%	-46.02%
FCF Margin	9.54%	7.72%	6.85%	-5.44%	-3.08%	-12.74%
EBITDA	99.14	78.9	39.34	-108.7	-140.98	-232.22
EBITDA Margin	6.63%	5.54%	3.14%	-10.30%	-16.40%	-34.79%
EBIT	44.83	24.15	-31.61	-189.13	-210.17	-286.35
EBIT Margin	3.00%	1.70%	-2.53%	-17.92%	-24.45%	-42.90%
Effective Tax Rate	30.95%	21.84%	0.30%	9.84%	7.38%	7.78%

SEC Filings: 10-K · 10-Q